Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO Trial

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: 9c763b7f54cd08c795959678178d042a00f44b3b
First added on: Feb 08, 2025